Envoy Medical receives Nasdaq extension to November 16, 2026 to cure bid price deficiency

Envoy Medical, Inc.

Company received Nasdaq notice granting additional 180-day period until November 16, 2026 to meet $1.00 minimum bid price.
Initial compliance period ended May 18, 2026; company had not yet satisfied the bid price requirement.
Extension based on meeting other listing requirements and written intent to cure via reverse stock split if needed.
If not cured by new deadline, common stock may be delisted from Nasdaq Capital Market.

item 3.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-060556
form_type: 8-K
ticker: COCH
cik: 0001840877
company_name: Envoy Medical, Inc.
filed_at: 2026-05-22T20:05:31+00:00
discovered_at: 2026-05-22T20:07:00.267305+00:00
generated_at: 2026-05-22T20:08:01.459469+00:00
sec_items: ["3.01"]
event_type: other
sentiment: negative
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-060556
json_url: https://secwatch.observer/filing/0001213900-26-060556.json
markdown_url: https://secwatch.observer/filing/0001213900-26-060556.md
text_url: https://secwatch.observer/filing/0001213900-26-060556.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/ea0292043-8k_envoy.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

b6bfe89869c8cd123c9ece33912fd4738be76fa9

Envoy Medical, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

On May 19, 2026, the Company received a second staff notification from Nasdaq informing the Company that, although the Company had not met the Bid Price Requirement by the Compliance Date, the Company is eligible for an additional 180 day period, until November 16, 2026, to meet the Bid Price Requirement

SEC 8-K Item 3.01 confidence 0.95 SEC evidence

Source: SEC EDGAR

accession 0001213900-26-060556

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.